InvestorsHub Logo

Patientspeople

06/29/18 4:45 PM

#232818 RE: top123 #232810

You are correct Sir!!! Brilicidin as great topline results already in a successful Phase 2 trial... will be great for Patients and Healthcare Providers that know all to well how horrible Severe Oral Mucositis is and how debilitating and extremely painful it is on a Patients body and spirit. Cancer treatments are often delayed as well. It should be a slam dunk for FDA Breakthrough Designation!!! It will also be a very attractive niche drug for an Oncology Franchise (Big Pharma or Biotech) that already has a salesforce calling on Oncology.